Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy
James L. Januzzi, Javed Butler, Stefano Del Prato, Justin A. Ezekowitz, Nasrien E. Ibrahim, Carolyn S.P. Lam, Gregory D. Lewis, Thomas H. Marwick, Julio Rosenstock, W.H. Wilson Tang, Faı̈ez Zannad, Francesca Lawson, Riccardo Perfetti, Alessia Urbinati
Topics & Concepts
MedicinePolyol pathwayHeart failureAldose reductaseTolerabilityDiabetic cardiomyopathyCardiologyInternal medicineDiabetes mellitusPlaceboCardiomyopathyHeart diseaseClinical endpointRandomized controlled trialEndocrinologyAdverse effectPathologyAlternative medicineAldose Reductase and TaurineCardiovascular, Neuropeptides, and Oxidative Stress ResearchHormonal Regulation and Hypertension